insights_auto
Why is CUV down 2,84%?
Dive Deeperchevron_right
CUV:ASX
Clinuvel Pharmaceuticals Ltd
A$7,52
arrow_downward
-2,84%(-0,22) 1D
6 Nov., 16:10:28 GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CUV...
Open
A$8,30
High
A$8,30
Low
A$7,39
Mkt. cap
379,66Â m
Avg. vol.
157,70Â k
Volume
172,46Â k
Dividend
0,66%
Quarterly dividend
A$0,01
Ex-dividend date
03 Sep. 2026
P/E ratio
11,26
52-wk high
A$13,48
52-wk low
A$6,62
EPS
A$0,67
Shares outstanding
50,49Â m
No. of employees
16
Open
A$8,30
High
A$8,30
Low
A$7,39
Mkt. cap
379,66Â m
Avg. vol.
157,70Â k
Volume
172,46Â k
Dividend
0,66%
Quarterly dividend
A$0,01
Ex-dividend date
03 Sep. 2026
P/E ratio
11,26
52-wk high
A$13,48
52-wk low
A$6,62
EPS
A$0,67
Shares outstanding
50,49Â m
No. of employees
16
News stories
From web sources and news partners
AP News
·
4 uur gelede
From high-flying AI stocks to tariff-hit alcohol companies, the midterms shook up Wall Street
Yahoo Finance
·
6 uur gelede
Tech stocks are now cheaper than the S&P 500 for the first time since 2017 — here's what history says comes next: Chart of the Day
Bloomberg.com
·
1 dag gelede
Anatomy of a Selloff: Sudden Chain Reaction Rattles Wall Street
The Motley Fool
·
2 uur gelede
This Dividend King Yielding 2X the S&P 500 Looks Like a Buy in November.
About Clinuvel Pharmaceuticals Ltd
CEOPhilippe J. Wolgen
Employees16
Founded1987
Headquarters-
SectorHealth Care
Industry-
Websiteclinuvel.com